Develops drugs for rare diseases, cancers, and sleep disorders.
Jun 2026Revenue $4.60B/yrExpenses $3.70B/yr
No trend
Figures by year
Is Jazz Pharmaceuticals profitable?
Yes. In the 12 months to Jun 2026, revenue was $4.60B and expenses $3.70B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $4.27B | $4.70B | −$430M |
| Dec 2024 | $4.07B | $3.35B | $717M |
| Dec 2023 | $3.83B | $3.26B | $579M |
| Dec 2022 | $3.66B | $3.72B | −$65.5M |
| Dec 2021 | $3.09B | $2.92B | $170M |
| Dec 2020 | $2.36B | $1.99B | $378M |
| Dec 2019 | $2.16B | $1.63B | $532M |
| Dec 2018 | $1.89B | $1.28B | $615M |
| Dec 2017 | $1.62B | $1.09B | $529M |
| Dec 2016 | $1.49B | $896M | $592M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.